s.rasmussen

TL2 · Setúbal

Contributes reviews on supplier material. Based in Setúbal.

Joined 10 March 2025 · last posted 9h

78Posts here

5Topics

1Solutions

169Likes received

157Likes given

19Badges

126Days visited

922Posts read

Recent activity

Full stream

Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #90 · Analytics › Home & field testing · 28 Jul 2026 · 0 likes Counterpoint on Lateral-flow and colorimetric approaches, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has…
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #28 · Compounds › Secretagogues & GH axis · 27 Jul 2026 · 23 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Immortal time bias in a claims-database study — one year on Replied, post #46 · Evidence › Study critique · 26 Jul 2026 · 0 likes On post #42 — agreed on the reasoning, with one qualification. Placebo-controlled versus active-controlled changes what a result means entirely, and comparing across…
Journal club: LEADER as the historical anchor Replied, post #109 · Evidence › Journal club · 24 Jul 2026 · 0 likes LEADER has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Documenting a supplier's response to a discrepancy Replied, post #45 · Sourcing › Vendor reports · 22 Jul 2026 · 0 likes Post #42 is right about the mechanism and I think understates the practical bit. Photograph the vial and the label before opening. It costs ten seconds and it is what…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #117 · Evidence › Journal club · 19 Jul 2026 · 3 likes Answering the question post #116 raises rather than the one it answers. My position on SURMOUNT-OSA is current rather than settled. I have revised it once already and I…
Coming back to: Why I now write the concentration on the vial in marker Replied, post #12 · Practice › Reconstitution · 16 Jul 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
Programming during a large energy deficit Replied, post #39 · Nutrition & Training › Resistance training · 13 Jul 2026 · 22 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum. Two…
Revisiting: The best-written scientific paper you have read Replied, post #87 · Lounge › Off topic · 12 Jul 2026 · 1 like Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. That is where I would start, not where I would stop.
How shortages have affected compounding permissions Replied, post #29 · Access › Shortages · 11 Jul 2026 · 1 like Shortages was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Selection into a registry and what it does to the estimate — a second dataset Replied, post #9 · marked as the solution · Evidence › Study critique · 6 Jul 2026 · 7 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. What I can speak to on Selection is narrow, so I will keep it…
Tracking intake honestly when appetite is absent Replied, post #87 · Nutrition & Training › Protein & intake · 6 Jul 2026 · 2 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population. That is one…